<p>隨着全球市場因貿易緊張局勢緩解和美國股市反彈而顯現出樂觀跡象，投資者正在應對一個複雜的環境，該環境以經濟放緩和謹慎的消費者情緒為特徵。在這樣的環境中，擁有強大內部持股的公司尤其吸引人，因為這通常表明那些最瞭解業務的人對公司的信心。</p>
<h3>全球內部持股比例高的十大成長公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
<tr>
<td>Suzhou Gyz Electronic TechnologyLtd (SHSE:688260)</td>
<td>16.4%</td>
<td>121.7%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們快速增長的全球內部持股高的 844 只股票的完整列表。</p>
<p>以下是篩選器中的一些選擇。</p>
<h2>浙江偉明環保 (SHSE:603568)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 浙江偉明環保股份有限公司在環保行業運營，市值為 329.9 億人民幣。</p>
<p><strong>運營：</strong> 該公司主要通過其工業部門產生收入，金額為 71.7 億人民幣。</p>
<p><strong>內部持股：</strong> 24%</p>
<p>浙江偉明環保展現出強大的增長潛力，預計年收入增長 29.6%，超過中國市場的平均水平。儘管股息收益率為 2.46%，且未完全由自由現金流覆蓋，但該公司的相對價值良好，市盈率為 12.2 倍，遠低於市場平均水平。最近的財報顯示，2024 年淨收入從前一年的 20.48 億人民幣上升至 27.0388 億人民幣，表現穩定。</p>
<ul>
<li>解鎖我們對浙江偉明環保股票分析的全面見解，詳見本成長報告。</li>
<li>我們的浙江偉明環保估值報告中的分析暗示其股價相較於估計價值被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d22767e-617c-47a7-a32d-0702d330fdf7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d22767e-617c-47a7-a32d-0702d330fdf7/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 5 月的 SHSE:603568 收益和收入增長</p>
<h2>奇安信科技集團 (SHSE:688561)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 奇安信科技集團有限公司是一家網絡安全公司，向中國及國際的政府、企業和其他機構提供網絡安全產品和服務，市值約為 209.8 億人民幣。</p>
<p><strong>運營：</strong> 奇安信科技集團有限公司通過其針對政府機構、企業和各種機構的網絡安全產品和服務產生收入，覆蓋中國國內及國際市場。</p>
<p><strong>內部持股：</strong> 22%</p>
<p>奇安信科技集團的交易價格低於其估計公允價值的 43.2%，預計年收入將增長 20.9%，超過中國市場。儘管 2024 年淨虧損為 13.6 億人民幣，目前尚未盈利，但預計將在三年內實現盈利。儘管未來的股本回報率預測較低且波動性較高，但其估值顯示出對以增長為導向的投資者的潛在上行空間。</p>
<ul>
<li>點擊探索我們在奇安信科技集團收益增長報告中的詳細發現。</li>
<li>我們的估值報告顯示奇安信科技集團可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aabf5e41-e45f-4e0e-b547-15bab0c91da9/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aabf5e41-e45f-4e0e-b547-15bab0c91da9/chart/ownership-breakdown"/></p>
<p>截至 2025 年 5 月的 SHSE:688561 持股結構</p>
<h2>贏健康科技集團 (SZSE:300253)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 贏健康科技集團有限公司為中國的醫療和健康機構提供數字健康服務，市值為 225 億人民幣。</p>
<p><strong>運營：</strong> 贏健康科技集團有限公司通過向中國的醫療和健康機構提供數字健康服務來產生收入。</p>
<p><strong>內部持股：</strong> 22.2%</p>
<p>儘管贏健康科技集團最近財務遭遇挫折，2025 年第一季度收入為 3.4498 億人民幣，淨收入降至 529 萬人民幣，但預計年收益增長將接近 50%，超過中國市場平均水平。然而，其利潤率已從去年的數據中收縮，股價波動性仍然較高。近期沒有重大內部交易活動報告，未來前景取決於在當前挑戰中有效執行增長戰略。</p>
<ul>
<li>點擊這裏深入瞭解贏健康科技集團的完整分析未來增長報告。</li>
<li>我們的綜合估值報告提出贏健康科技集團的定價可能高於其財務狀況所能合理支持的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/ownership-breakdown"/></p>
<p>截至 2025 年 5 月的 SZSE:300253 持股結構</p>
<h2>關鍵要點</h2>
<ul>
<li>點擊這裏訪問我們完整的 844 家快速增長的全球內部持股高公司的索引。</li>
<li>想要探索一些替代方案？人工智能即將改變醫療保健。這 25 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們僅基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
<p>如果您想交易奇安信科技集團，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在超過 200 個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的水平。</p>
<p>贊助內容</p>

偉明環保

<p>隨着全球市場的改善，擁有高比例內部持股的公司正吸引投資者的關注。值得注意的公司包括 Seojin System（32.1% 內部持股，39.3% 盈利增長）、Pharma Mar（11.8%，43.1%）和 Qi An Xin Technology Group（22%，預計 20.9% 收入增長）。浙江偉明環保（24% 持股）顯示出強勁的增長潛力，預計收入將增長 29.6%。儘管一些公司面臨挑戰，但整體趨勢表明，擁有顯著內部持股的成長股前景樂觀</p>

<p>As global markets show signs of optimism with easing trade tensions and a rebound in U.S. equities, investors are navigating a complex landscape marked by economic slowdowns and cautious consumer sentiment. In such an environment, companies with strong insider ownership can be particularly appealing as they often indicate confidence from those who know the business best.</p>
<div class="lb-trans"><p>隨着全球市場因貿易緊張局勢緩解和美國股市反彈而顯現出樂觀跡象，投資者正在應對一個複雜的環境，該環境以經濟放緩和謹慎的消費者情緒為特徵。在這樣的環境中，擁有強大內部持股的公司尤其吸引人，因為這通常表明那些最瞭解業務的人對公司的信心。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3>
<div class="lb-trans"><h3>全球內部持股比例高的十大成長公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
<tr>
<td>Suzhou Gyz Electronic TechnologyLtd (SHSE:688260)</td>
<td>16.4%</td>
<td>121.7%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
<tr>
<td>Suzhou Gyz Electronic TechnologyLtd (SHSE:688260)</td>
<td>16.4%</td>
<td>121.7%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 844 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們快速增長的全球內部持股高的 844 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是篩選器中的一些選擇。</p>
</div><h2>Zhejiang Weiming Environment Protection (SHSE:603568)</h2>
<div class="lb-trans"><h2>浙江偉明環保 (SHSE:603568)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Zhejiang Weiming Environment Protection Co., Ltd. operates in the environmental protection industry and has a market cap of CN¥32.99 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 浙江偉明環保股份有限公司在環保行業運營，市值為 329.9 億人民幣。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its industrial segment, amounting to CN¥7.17 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司主要通過其工業部門產生收入，金額為 71.7 億人民幣。</p>
</div><p><strong>Insider Ownership:</strong> 24%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 24%</p>
</div><p>Zhejiang Weiming Environment Protection exhibits strong growth potential with forecasted revenue growth of 29.6% annually, surpassing the Chinese market’s average. Despite a modest dividend yield of 2.46% not fully covered by free cash flows, the company shows good relative value with a price-to-earnings ratio of 12.2x, well below the market average. Recent earnings reports indicate stable performance with net income rising to CNY 2,703.88 million for 2024 from CNY 2,048.49 million in the prior year.</p>
<div class="lb-trans"><p>浙江偉明環保展現出強大的增長潛力，預計年收入增長 29.6%，超過中國市場的平均水平。儘管股息收益率為 2.46%，且未完全由自由現金流覆蓋，但該公司的相對價值良好，市盈率為 12.2 倍，遠低於市場平均水平。最近的財報顯示，2024 年淨收入從前一年的 20.48 億人民幣上升至 27.0388 億人民幣，表現穩定。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Zhejiang Weiming Environment Protection stock in this growth report.</li>
<li>The analysis detailed in our Zhejiang Weiming Environment Protection valuation report hints at an deflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對浙江偉明環保股票分析的全面見解，詳見本成長報告。</li>
<li>我們的浙江偉明環保估值報告中的分析暗示其股價相較於估計價值被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8d22767e-617c-47a7-a32d-0702d330fdf7/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/8d22767e-617c-47a7-a32d-0702d330fdf7/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:603568 Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 SHSE:603568 收益和收入增長</p>
</div><h2>Qi An Xin Technology Group (SHSE:688561)</h2>
<div class="lb-trans"><h2>奇安信科技集團 (SHSE:688561)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Qi An Xin Technology Group Inc. is a cyber-security company that offers cybersecurity products and services to government, enterprises, and other institutions both in China and internationally, with a market cap of approximately CN¥20.98 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 奇安信科技集團有限公司是一家網絡安全公司，向中國及國際的政府、企業和其他機構提供網絡安全產品和服務，市值約為 209.8 億人民幣。</p>
</div><p><strong>Operations:</strong> Qi An Xin Technology Group Inc. generates revenue through its cybersecurity products and services targeted at government bodies, enterprises, and various institutions both domestically in China and on an international scale.</p>
<div class="lb-trans"><p><strong>運營：</strong> 奇安信科技集團有限公司通過其針對政府機構、企業和各種機構的網絡安全產品和服務產生收入，覆蓋中國國內及國際市場。</p>
</div><p><strong>Insider Ownership:</strong> 22%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 22%</p>
</div><p>Qi An Xin Technology Group, trading at 43.2% below its estimated fair value, is poised for significant growth with revenue expected to rise by 20.9% annually, outpacing the Chinese market. Although currently unprofitable with a net loss of CNY 1.36 billion in 2024, it is forecasted to become profitable within three years. Despite high volatility and low future return on equity projections, its valuation suggests potential upside for growth-focused investors.</p>
<div class="lb-trans"><p>奇安信科技集團的交易價格低於其估計公允價值的 43.2%，預計年收入將增長 20.9%，超過中國市場。儘管 2024 年淨虧損為 13.6 億人民幣，目前尚未盈利，但預計將在三年內實現盈利。儘管未來的股本回報率預測較低且波動性較高，但其估值顯示出對以增長為導向的投資者的潛在上行空間。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Qi An Xin Technology Group's earnings growth report.</li>
<li>Our valuation report here indicates Qi An Xin Technology Group may be undervalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊探索我們在奇安信科技集團收益增長報告中的詳細發現。</li>
<li>我們的估值報告顯示奇安信科技集團可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/aabf5e41-e45f-4e0e-b547-15bab0c91da9/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/aabf5e41-e45f-4e0e-b547-15bab0c91da9/chart/ownership-breakdown"/></p>
<p>SHSE:688561 Ownership Breakdown as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 SHSE:688561 持股結構</p>
</div><h2>Winning Health Technology Group (SZSE:300253)</h2>
<div class="lb-trans"><h2>贏健康科技集團 (SZSE:300253)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Winning Health Technology Group Co., Ltd. provides digital health services for medical and health institutions in China and has a market cap of CN¥22.50 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 贏健康科技集團有限公司為中國的醫療和健康機構提供數字健康服務，市值為 225 億人民幣。</p>
</div><p><strong>Operations:</strong> Winning Health Technology Group Co., Ltd. generates revenue by offering digital health services to medical and health institutions across China.</p>
<div class="lb-trans"><p><strong>運營：</strong> 贏健康科技集團有限公司通過向中國的醫療和健康機構提供數字健康服務來產生收入。</p>
</div><p><strong>Insider Ownership:</strong> 22.2%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 22.2%</p>
</div><p>Winning Health Technology Group, despite recent financial setbacks with Q1 2025 revenue at CNY 344.98 million and net income dropping to CNY 5.29 million, is forecasted for robust earnings growth of nearly 50% annually, surpassing the Chinese market average. However, its profit margins have contracted from last year's figures and share price volatility remains high. With no substantial insider trading activity recently reported, future prospects hinge on executing growth strategies effectively amidst current challenges.</p>
<div class="lb-trans"><p>儘管贏健康科技集團最近財務遭遇挫折，2025 年第一季度收入為 3.4498 億人民幣，淨收入降至 529 萬人民幣，但預計年收益增長將接近 50%，超過中國市場平均水平。然而，其利潤率已從去年的數據中收縮，股價波動性仍然較高。近期沒有重大內部交易活動報告，未來前景取決於在當前挑戰中有效執行增長戰略。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Winning Health Technology Group.</li>
<li>Our comprehensive valuation report raises the possibility that Winning Health Technology Group is priced higher than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏深入瞭解贏健康科技集團的完整分析未來增長報告。</li>
<li>我們的綜合估值報告提出贏健康科技集團的定價可能高於其財務狀況所能合理支持的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/ownership-breakdown"/></p>
<p>SZSE:300253 Ownership Breakdown as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 SZSE:300253 持股結構</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><ul>
<li>Click here to access our complete index of 844 Fast Growing Global Companies With High Insider Ownership.</li>
<li>Want To Explore Some Alternatives? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏訪問我們完整的 844 家快速增長的全球內部持股高公司的索引。</li>
<li>想要探索一些替代方案？人工智能即將改變醫療保健。這 25 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們僅基於歷史數據和分析師預測提供評論，採用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有預測的收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
</div><p>If you're looking to trade Qi An Xin Technology Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易奇安信科技集團，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在超過 200 個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的水平。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

內部人士持有這些全球增長型股票的股份高達 24%